CZMWY (CZMWY) Stock Price & Analysis
CZMWY (CZMWY) rose 1.06% to USD 31.4 as of July 26, 2026 at 11:58 UTC, according to Nexqual real-time market data.
CZMWY last closed at USD 31.07; the session ranged USD 31–31.21 on volume of 427 shares. Market capitalization is $2.75B, with a 52-week range of USD 26.65–59.48 (PNK). Source: Nexqual, July 26, 2026 at 11:58 UTC.
Key Statistics (as of July 26, 2026 at 11:58 UTC)
| Price | USD 31.4 |
|---|---|
| Change | ▲ 1.06% (up) |
| Previous Close | USD 31.07 |
| Open | USD 31.21 |
| Day Range | USD 31 – 31.21 |
| 52-Week Range | USD 26.65 – 59.48 |
| Volume | 427 shares |
| Market Cap | $2.75B |
| Exchange | PNK |
Technical Analysis (CZMWY)
Nexqual's technical model rates CZMWY "NEUTRAL" based on 3 bullish and 3 bearish signals across 125 daily candles, as of July 26, 2026 at 11:58 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 46.85 (neutral) |
| vs SMA50 | Above (USD 30.95) |
| MACD | 0.29 (positive) |
Analyst Ratings (CZMWY)
Wall Street analysts rate CZMWY "None", per Nexqual as of July 26, 2026 at 11:58 UTC.
| Consensus Rating | None |
|---|
Earnings (CZMWY)
| Revenue Estimate | $540.90M |
|---|
Source: Nexqual, July 26, 2026 at 11:58 UTC.
Financials & Fundamentals (CZMWY)
| Total Revenue | $2.17B |
|---|---|
| Revenue Growth (YoY) | -6.40% |
| Gross Margin | +51.28% |
| Operating Margin | +4.86% |
| Profit Margin | +4.38% |
| ROE | +4.54% |
| Debt / Equity | 27.56 |
| Current Ratio | 2.43 |
| Total Cash | $23.90M |
| Total Debt | $580.95M |
| Free Cash Flow | $88.17M |
Source: Nexqual, July 26, 2026 at 11:58 UTC.
Financial Health Score (CZMWY)
Nexqual rates CZMWY's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 11:58 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 51%, operating 5% |
| Balance Sheet | Strong — $24M cash vs $581M debt |
| Cash Flow | Mixed — FCF $88M, slim 4.0% margin |
| Efficiency | Weak — ROE 5%, ROA 2.7% |
Ownership (CZMWY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 87.54M |
| Float | 34.68M |
Source: Nexqual, July 26, 2026 at 11:58 UTC.
Leadership (CZMWY)
CZMWY is led by Andreas Pecher (age 54), Interim Chairman of the Management Board & Interim CEO, per Nexqual as of July 26, 2026 at 11:58 UTC.
| Interim Chairman of the Management Board & Interim CEO | Andreas Pecher (age 54) |
|---|---|
| CFO & Member of the Management Board | Justus Felix Wehmer (age 60) |
| Chief Operating Officer | Stefanie Spanagel |
| Director of Investor Relations | Sebastian Frericks |
| Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc. | Andrew Chang |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CZMWF | Carl Zeiss Meditec AG | USD 33.5 | ▲ 0% |
| HOCPY | Hoya Corp. | USD 149.26 | ▼ 3.12% |
| CHEOY | CochLear Ltd. | USD 39.04 | ▲ 0.03% |
| SAUHY | Straumann Holding AG | USD 11.64 | ▼ 1.61% |
| SSMXY | Sysmex Corp. | USD 9.29 | ▼ 1.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 11:58 UTC. This page is informational and not investment advice.